BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 15172852)

  • 1. Ovarian cancer risk after the use of ovulation-stimulating drugs.
    Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
    Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk associated with ovulation-stimulating drugs.
    Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
    Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine cancer after use of clomiphene citrate to induce ovulation.
    Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
    Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.
    Sanner K; Conner P; Bergfeldt K; Dickman P; Sundfeldt K; Bergh T; Hagenfeldt K; Janson PO; Nilsson S; Persson I
    Fertil Steril; 2009 Apr; 91(4):1152-8. PubMed ID: 18371964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood tumor risk after treatment with ovulation-stimulating drugs.
    Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
    Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
    Althuis MD; Scoccia B; Lamb EJ; Moghissi KS; Westhoff CL; Mabie JE; Brinton LA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):668-74. PubMed ID: 16150258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.
    Jensen A; Sharif H; Kjaer SK
    Am J Epidemiol; 2009 Dec; 170(11):1408-14. PubMed ID: 19884127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
    Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
    Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer risk associated with varying causes of infertility.
    Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
    Fertil Steril; 2004 Aug; 82(2):405-14. PubMed ID: 15302291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis.
    Kashyap S; Moher D; Fung MF; Rosenwaks Z
    Obstet Gynecol; 2004 Apr; 103(4):785-94. PubMed ID: 15051576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulation induction treatment and risk of borderline ovarian tumors.
    Cusidó M; Fábregas R; Pere BS; Escayola C; Barri PN
    Gynecol Endocrinol; 2007 Jul; 23(7):373-6. PubMed ID: 17701767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
    Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cancer and fertility medications: a critical appraisal.
    Kashyap S; Davis OK
    Semin Reprod Med; 2003 Feb; 21(1):65-71. PubMed ID: 12806561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility drug use and risk of ovarian tumors: a debated clinical challenge.
    Gadducci A; Guerrieri ME; Genazzani AR
    Gynecol Endocrinol; 2013 Jan; 29(1):30-5. PubMed ID: 22946709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer after successful ovulation induction: a case report.
    Hull ME; Kriner M; Schneider E; Maiman M
    J Reprod Med; 1996 Jan; 41(1):52-4. PubMed ID: 8855076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infertility and ovarian cancer.
    Chatterjee SK
    J Indian Med Assoc; 1999 Feb; 97(2):69. PubMed ID: 10549200
    [No Abstract]   [Full Text] [Related]  

  • 17. Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.
    Lerner-Geva L; Keinan-Boker L; Blumstein T; Boyko V; Olmar L; Mashiach S; Rabinovici J; Potashnik G; Lunenfeld E; Schenker JG; Shushan A; Fishman A; Cohen I; Vagman I; Lunenfeld B
    Breast Cancer Res Treat; 2006 Nov; 100(2):201-12. PubMed ID: 16685587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study.
    Hannibal CG; Jensen A; Sharif H; Kjaer SK
    Hum Reprod; 2008 Feb; 23(2):451-6. PubMed ID: 18065402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study.
    Hannibal CG; Jensen A; Sharif H; Kjaer SK
    Cancer Causes Control; 2008 Sep; 19(7):759-65. PubMed ID: 18340541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.